[1] |
Kurman RJ, Carcangiu ML, Herrington S, et al. WHO classification of tumours of female reproductive organs [M]. 4th ed. Lyon: IARC, 2014: 38-40.
|
[2] |
宋光耀,王亚萍,李广慧,等. 卵巢交界性浆黏液性肿瘤的临床病理学特征[J]. 中国医师进修杂志,2019, 42(1): 10-13.
|
[3] |
董燕燕,刘云霄,屈重霄. 卵巢交界性浆黏液性肿瘤临床病理特征分析[J]. 肿瘤研究与临床,2018, 30(9): 603-606.
|
[4] |
孙力,宋艳,李宁,等. 黏液性卵巢交界性肿瘤的临床病理特征及复发危险因素[J]. 中华肿瘤杂志,2017, 39(8): 589-594.
|
[5] |
陈友权,魏清,张玉荣,等. 卵巢交界性肿瘤12例临床病理分析[J]. 中国现代医生,2018, 56(23): 133-136.
|
[6] |
Newton CL, Brockbank E, Singh N, et al. A case of stage 4B seromucinous ovarian borderline tumor with endometriosis and review of the literature[J]. Int J Gynecol Pathol, 2017, 36(2): 195-199.
|
[7] |
Kurata Y, Kido A, Moribata Y, et al. Differentiation of seromucinous borderline tumor from serous borderline tumor on MR imaging[J]. Magn Reson Med Sci, 2018, 17(3): 211-217.
|
[8] |
Nakamura E, Sato Y, Moriguchi S, et al. Ovarian seromucinous borderline tumor and clear cell carcinoma: an unusual combination[J]. Case Rep Obstet Gynecol, 2015, 2015: 690891.
|
[9] |
Karpathiou G, Chauleur C, Corsini T, et al. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors[J]. Ann Diagn Pathol, 2017, 27: 28-33.
|
[10] |
D′Angelo E, Dadmanesh F, Pecorelli S, et al. Squamous cell carcinoma of the ovary arising from a mucinous cystic tumor of endocervical (müllerian) type[J]. Int J Gynecol Pathol, 2010, 29(6): 529-532.
|
[11] |
Fox H, Langley FA. Tumors of the Ovary[M]. Chicago: William Heinemann, 1976: 252.
|
[12] |
Rutgers JL, Scully RE. Ovarian Mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis[J]. Cancer, 1988, 61(2): 340-348.
|
[13] |
Rutgers JL, Scully RE. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy. A clinicopathologic analysis[J]. Cancer, 1988, 61(3): 546-554.
|
[14] |
Shappell HW, Riopel MA, Smith Sehdev AE, et al. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas[J]. Am J Surg Pathol, 2002, 26(12): 1529-1541.
|
[15] |
Tavassoli FA, Devilee P. 乳腺及女性生殖器官肿瘤病理学和遗传学[M].程虹,译. 北京:人民卫生出版社,2006: 171-176.
|
[16] |
Kurman RJ, Shih IM. Seromucinous tumors of the ovary. What′s in a name?[J]. Int J Gynecol Pathol, 2016, 35(1): 78-81.
|
[17] |
郑文新,沈丹华,郭东辉. 妇产科病理学[M]. 北京:科学出版社,2013: 587-588.
|
[18] |
倪皓,周晓军. 免疫组化在卵巢交界性肿瘤诊断和鉴别诊断中的研究进展[J].诊断病理学杂志,2016, 23(6): 462-465.
|
[19] |
Chene G, Ouellet V, Rahimi K, et al. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis[J]. Int J Gynaecol Obstet, 2015, 130(1): 27-30.
|
[20] |
Kim KR, Choi J, Hwang JE, et al. Endocervical-like (Müllerian) mucinous borderline tumors of the ovary are frequently associated with the KRAS mutation[J]. Histopathology, 2010, 57(4): 587-596.
|
[21] |
Matias-Guiu X, Stewart CJR. Endometriosis-associated ovarian neoplasia[J]. Pathology, 2018, 50(2): 190-204.
|
[22] |
Taylor J, McCluggage WG. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm[J]. Am JSurgPathol, 2015, 39(7): 983-992.
|
[23] |
唐绍娴,孙艺华,许燕. 卵巢浆黏液性癌临床病理学分析[J].中华病理学杂志,2016, 45(11): 774-779.
|